FCRL5 and Miyoshi myopathy: Analysis of ∼20 primary MM biopsies demonstrated a significant association between FcRH5 RNA expression and 1q21 gain (Figures 4E–4F), demonstrating that the 1q21 gain can lead to FcRH5 overexpression in high-risk myeloma patients.